Qube Research & Technologies (QRT)’s Nautilus Biotechnolgy NAUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$481K Buy
257,346
+177,723
+223% +$469K ﹤0.01% 2665
2026
Q1
$309K Sell
79,623
-43,498
-35% -$107K ﹤0.01% 2857
2025
Q4
$240K Buy
123,121
+71,454
+138% +$117K ﹤0.01% 3011
2025
Q3
$43.7K Sell
51,667
-10,471
-17% -$7.7K ﹤0.01% 3198
2025
Q2
$45K Buy
+62,138
New +$46.7K ﹤0.01% 3166
2022
Q1
Sell
-25,166
Closed -$130K 2807
2021
Q4
$130K Buy
25,166
+10,138
+67% +$54.3K ﹤0.01% 2081
2021
Q3
$92K Buy
+15,028
New +$120K ﹤0.01% 1806

Other funds holding NAUT

Qube Research & Technologies (QRT)'s NAUT Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Nautilus Biotechnolgy (NAUT) stake by 223% in Q2 2026, buying an estimated $469K and bringing the position to 257,346 shares worth $481K. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

Qube Research & Technologies (QRT) first reported a position in NAUT in Q3 2021 and has held it in 7 quarters since. 93 funds tracked by Wall St. Rank hold NAUT as of Q2 2026.

  • Qube Research & Technologies (QRT) held 257,346 shares of Nautilus Biotechnolgy worth $481K as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 177,723 Nautilus Biotechnolgy shares in Q2 2026, an estimated $469K.
  • Nautilus Biotechnolgy made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2665 holding.
  • Qube Research & Technologies (QRT) first reported a position in Nautilus Biotechnolgy in Q3 2021 and has held it in 7 quarters since.
  • 93 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.